• Bicara Therapeutics granted inducement stock options on July 1, 2026 to four new employees covering 191,425 shares.
• Options carry a USD 28.91 exercise price, matching the Nasdaq closing price on July 1.
• Vesting: 25% on the first anniversary of each employee’s start date, remainder in 12 equal quarterly installments, subject to continued service.
• Awards were issued under the board-adopted 2026 Inducement Plan, outside stockholder-approved equity incentive plans.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bicara Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607020830PRIMZONEFULLFEED9756133) on July 02, 2026, and is solely responsible for the information contained therein.